SCHEMBL4089863

SCHEMBL4089863

CCc1c(CC(=O)O)cccc1-c1cccc(OCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 6/20 0.59
PTGER3 P43115 6/20 0.59
PTGER1 P34995 5/20 0.59
PTGER2 P43116 5/20 0.59
CFD P00746 2/20 0.57
FFAR1 O14842 5/20 0.49
ENPP2 Q13822 1/20 0.49
FABP3 P05413 1/20 0.48
FABP4 P15090 1/20 0.48
FABP5 Q01469 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
MAOB P27338 1/20 0.48
CD274 Q9NZQ7 1/20 0.47
NR4A2 P43354 1/20 0.47
PLG P00747 1/20 0.46
PLAU P00749 1/20 0.46
F11 P03951 1/20 0.46
KLKB1 P03952 1/20 0.46
F7 P08709 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18076580 0.80 PTGER4 (0.61) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL13802494 0.79 PTGER1 (0.57) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL4089867 0.79 PTGER1 (0.61) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL28451933 0.78 PTGER4 (0.60) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL27711541 0.77 PTGER4 (0.55) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL3908596 0.77 CFD (0.66) CFDFFAR1ENPP2FFAR4MRGPRX4
SCHEMBL7710805 0.76 PTGER4 (0.55) PTGER4PTGER3PTGER1PTGER2CFD
SCHEMBL962238 0.76 FFAR1 (0.60) FFAR1FFAR4MRGPRX4MAOB
SCHEMBL7743316 0.75 MRGPRX4 (0.60) PTGER1MRGPRX4MAOBNR4A2
SCHEMBL4941479 0.74 AKR1B1 (0.43) PTGER4PTGER3PTGER1PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553867-B2 Furan or thiophene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-30 US disclosed
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED INTELLECTUAL PROPERTY DEPARTMENT (JP) 2006-05-11 US disclosed
EP-1535915-A1 FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100261-A1 Furan or thiopene derivative and medicinal use thereof TXN2, CYP11B2, CYP11B1 PTGER4 115/4885PTGER3 117/4885PTGER1 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.